Kingsview Wealth Management LLC Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

Kingsview Wealth Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 70.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,715 shares of the healthcare conglomerate’s stock after selling 23,012 shares during the quarter. Kingsview Wealth Management LLC’s holdings in UnitedHealth Group were worth $4,038,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $25,000. Anfield Capital Management LLC lifted its holdings in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares during the period. Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. Finally, Wilkerson Advisory Group LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by company insiders.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research note on Tuesday, July 21st. Cantor Fitzgerald reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. UBS Group upped their price target on UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Finally, Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research report on Friday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $456.56.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $393.99 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company’s 50-day moving average price is $413.28 and its 200-day moving average price is $360.11. The company has a market cap of $353.64 billion, a PE ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s revenue was up .4% on a year-over-year basis. During the same quarter last year, the business posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.